Delivery Order SPE2DB25D3008-SPE2DB25FRCFV
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, RINVOQ ER 30 MG TABLET, with a firm fixed price of $27,591.10 and a performance period ending on May 29, 2025. The contract is not set aside and was awarded on May 28, 2025. Amerisourcebergen Drug Corp, a for-profit organization headquartered in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30 milligram tablets of the medication RINVOQ ER. The contract has a firm fixed price of $15,025.10 and a completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Rinvoq ER 15 mg tablet, with a ceiling value of $19,659.23 and a performance period through May 6, 2025. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,968.86, is for the delivery of the prescription medication Rinvoq ER 30 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical drug Rinvoq ER 15 mg tablets, with a total ceiling value of $7,407.24 and a period of performance through May 14, 2024. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (Corporate Office Division) for the supply of Rinvoq ER 15 mg tablets. The contract has a firm fixed price and a ceiling value of $15,956.48. The performance period extends through September 4, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $4,533.62 and a period of performance through May 29, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp, as the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,071.05, is for the delivery of the drug RINVOQ ER 15 MG TABLET UU 30S. It is a firm fixed-price contract with a completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rinvoq ER 15 mg tablets. The contract has a firm fixed price, with a ceiling value of $100,364.96, and a period of performance through May 29, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rinvoq ER 15 mg tablets, a medication used to treat certain types of arthritis. The contract has a firm fixed price of $25,545.25 and a period of performance ending on May 15, 2025. The contract is not set aside for any particular type of business. Amerisourcebergen Drug Corp holds...